Letrozol Denk

Letrozole, the active ingredient in Letrozol Denk, is an aromatase inhibitor presented as a tablet for oral use. It treats hormone‑receptor positive breast cancer in post‑menopausal women. GNH USA supplies Letrozol Denk as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Letrozol Denk as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Letrozole acts by targeting the estrogen‑production pathway in hormone‑dependent cancers.

- Breast Cancer (post‑menopausal): Reduces the risk of disease recurrence and improves overall survival. - Endocrine Disruption of the menstrual cycle : Provides symptom relief for women with ovarian cysts or PCOS by lower estrogen levels. - Fertility Pres‑‑ pres        -    \